Gerresheimer (ETR:GXI) Trading Down 0.3%

traded during the session, an increase of 122% from the average daily volume of 162,836 shares. The stock had previously closed at 99.60 ($109.44). The stock price of Gerresheimer AG traded down 0.3% on Friday. The stock had previously closed at 99.60 ($109.44).

The share price of '' fell by 0.3% on Friday. The stock was last traded at EUR99.30 ($109.12) after trading as low as EUR98.80. During trading, 361,800 stocks were traded, a 157% increase from the session average of 140,925. The stock closed previously at EUR99.60 (US$109.45).

Analyst Upgrades and downgrades

Recently, several analysts commented on the stock. JPMorgan Chase & Co. established a EUR144.10 (158.35 USD) target price for Gerresheimer on Friday, 24th March. The company's debt-to equity ratio is 111.50. It also has a current and quick ratios of 0.87, 0.40 and 0.87. The company has a $3.12 billion market cap, a 29.82 price-to earnings ratio, a P/E/G of 0.82, and a beta value of 1.01. The company has a simple moving-average of EUR89.75 for the last fifty days and EUR74.77 for the past two hundred days.

Gerresheimer Company profile

Get Rating

Gerresheimer AG and its subsidiaries manufacture and sell packaging products and drug delivery devices and solutions in the world. It is divided into three divisions: Plastics & Devices Primary Packaging Glass and Advanced Technologies. Plastics & Devices offers drug delivery systems including insulin pen systems and prefillable syringes for the pharma and biotech industries, as well as diagnostic systems and other medical devices. It also provides containers and closures such PET bottles, eyedroppers, nasal sprays and applicators for liquids and solids. offers a FREE daily email newsletter